![Bo Liang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Bo Liang
Società | Posizione | Inizio | Fine |
---|---|---|---|
Shanghai Zhimeng Biopharma, Inc.
![]() Shanghai Zhimeng Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Shanghai Zhimeng Biopharma, Inc. is a clinical-stage biopharmaceutical company located in the resource-rich Zhangjiang High Tech Park of Shanghai, China. The Chinese company is committed to developing innovative drugs for the treatment of chronic hepatitis B (CHB) and severe neurological diseases with significant unmet medical needs. Founded in 2017, Zhimeng Pharmaceutical Technology Co., Ltd. is a biotechnology company dedicated to the development of drugs for the treatment of CHB and related liver diseases. The company was founded by Huan Ming Chen, Zhi Jun Zhang, and Bo Liang, with Huan Ming Chen serving as the CEO since 2015. | Fondatore | 26/10/2015 | - |
Corporate Officer/Principal | 26/10/2015 | - |
Storia della carriera di Bo Liang
Statistiche
Distribuzione geografica
Cina | 2 |
Posizioni
Founder | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Shanghai Zhimeng Biopharma, Inc.
![]() Shanghai Zhimeng Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Shanghai Zhimeng Biopharma, Inc. is a clinical-stage biopharmaceutical company located in the resource-rich Zhangjiang High Tech Park of Shanghai, China. The Chinese company is committed to developing innovative drugs for the treatment of chronic hepatitis B (CHB) and severe neurological diseases with significant unmet medical needs. Founded in 2017, Zhimeng Pharmaceutical Technology Co., Ltd. is a biotechnology company dedicated to the development of drugs for the treatment of CHB and related liver diseases. The company was founded by Huan Ming Chen, Zhi Jun Zhang, and Bo Liang, with Huan Ming Chen serving as the CEO since 2015. | Health Technology |
- Borsa valori
- Insiders
- Bo Liang
- Esperienza